High PGC1α levels were associated with doxorubicin resistance in melanomas, likely due to increased antioxidant defense [40], and with chemoresistance-promoting proteins MDR1 and ABCG2 in an ovarian cancer cell line made to overexpress PGC1α [38]. The gene discussed is PPARGC1A; the disease is ovarian carcinoma.